Asarfi Hospital zooms after signing MoU with Gleneagles Hospital, Chennai
Asarfi Hospital is currently trading at Rs 120.90, up by 3.93 points or 3.36% from its previous closing of Rs 116.97 on the BSE.
The scrip opened at Rs 114.90 and has touched a high and low of Rs 122.00 and Rs 109.00 respectively. So far 107000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs 10 has touched a 52-week high of Rs 122.00 on 20-May-2025 and a 52-week low of Rs 52.84 on 07-Oct-2024.
Last one week high and low of the scrip stood at Rs 122.00 and Rs 93.01 respectively. The current market cap of the company is Rs 236.58 crore.
The promoters holding in the company stood at 61.17%, while Institutions and Non-Institutions held 2.92% and 35.91% respectively.
Asarfi Hospital has signed a Memorandum of Understanding (MoU) with Gleneagles Hospital, Chennai, to set up Jharkhand’s first Multi-Organ Transplant Unit at its hospital in Dhanbad. This initiative represents a major milestone in advancing the healthcare landscape of the state. The transplant center will offer comprehensive and world-class transplant services for heart, lungs, kidneys, liver, and bone marrow, making it the first of its kind in Jharkhand.
This collaboration addresses the critical need for local transplant services, reducing the burden on patients who previously had to travel to metro cities such as Delhi, Mumbai, or Chennai for such life-saving procedures. Asarfi Hospital is empanelled under the Jharkhand Government’s Mukhyamantri Gambhir Bimari Upchar Yojana (MGBUY), providing financial aid ranging from Rs 15 to Rs 25 lakh for eligible patients, thereby making high-end medical care more accessible to economically disadvantaged sections.
Asarfi Hospital is an integrated healthcare service provider, committed to deliver valued healthcare services to its patients that includes prevention, treatment and proper rehabilitation.
